NeoProfen recalled

Lundbeck Inc. has recalled two lots of NeoProfen (ibuprofen lysine) that failed to meet a visible particulate quality requirement. NeoProfen is used to close a clinically significant patent ductus arteriosus (PDA) in premature infants. Read more here.

LEAVE A REPLY

Please enter your comment!
Please enter your name here